Overview
Properties
Constituents: 0.1M Sodium chloride, 0.05M Sodium acetate, 1mM EDTA, pH 5.0
Concentration information loading...Applications
Our Abpromise guarantee covers the use of ab92767 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| SDS-PAGE | |
| Functional Studies |
SDS-PAGE: Use at an assay dependent dilution.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Protein info
-
Alternative names
- ATFATF uPABDPLT5
- OTTHUMP00000019849Plasminogen activatorPlasminogen activator urinaryPlasminogen activator urokinasePLAUQPDu PAU plasminogen activatoru-PAU-plasminogen activatorUPAURKUROK_HUMANUrokinase plasminogen activatorUrokinase type plasminogen activatorUrokinase type plasminogen activator precursorUrokinase-type plasminogen activator chain B
see all
Contains 1 EGF-like domain.
Contains 1 kringle domain.
Contains 1 peptidase S1 domain.
modificationsPhosphorylation of Ser-158 and Ser-323 abolishes proadhesive ability but does not interfere with receptor binding.
Target information above from: UniProt accession
P00749
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
Urokinase protein (Human) images
-
10% SDS-PAGE analysis of ab92767:
Lane 1. 3ug ab92767 non reduced
Lane 2. 3ug ab92767 + 12ug PAI-1 non reduced
Lane 3. Prestained standard
References for Urokinase protein (Human) (ab92767)
ab92767 has not yet been referenced specifically in any publications.
